“Utilization of DCVax-L in both arms of the trial is conclusive evidence that the UCLA combo trial investigators have plenty evidence that the vaccine (DCVax-L) has mucho efficacy. The shorts are therefore desperate to prove that the vaccine is not DCVax-L. “